Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Renata Auriemma"'
Autor:
Marina Picillo, Rosario Pivonello, Gabriella Santangelo, Claudia Pivonello, Riccardo Savastano, Renata Auriemma, Marianna Amboni, Sara Scannapieco, Angela Pierro, Annamaria Colao, Paolo Barone, Maria Teresa Pellecchia
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186508 (2017)
Cognitive deficits are common in Parkinson's disease (PD) since the early stages and many patients eventually develop dementia. Yet, occurrence of dementia in PD is unpredictable. Evidence supports the hypothesis that insulin-like growth factor-1 (IG
Externí odkaz:
https://doaj.org/article/d47fcf71440641d8abf88e532ef6a17d
Autor:
Elisa Maseroli, Nunzia Verde, Sarah Cipriani, Noemi Fralassi, Diletta Costeniero, Prof. Mario Maggi, Prof. Renata Auriemma, Prof. Annamaria Colao, Prof. Rosario Pivonello, Prof. Linda Vignozzi
Publikováno v:
The Journal of Sexual Medicine. 19:S32
Autor:
Patrick Petrossians, Adrian F Daly, Emil Natchev, Luigi Maione, Karin Blijdorp, Mona Sahnoun-Fathallah, Renata Auriemma, Alpha M Diallo, Anna-Lena Hulting, Diego Ferone, Vaclav Hana, Silvia Filipponi, Caroline Sievers, Claudia Nogueira, Carmen Fajardo-Montañana, Davide Carvalho, Günter K Stalla, Marie-Lise Jaffrain-Réa, Brigitte Delemer, Annamaria Colao, Thierry Brue, Sebastian J C M M Neggers, Sabina Zacharieva, Philippe Chanson, Albert Beckers
Publikováno v:
ENDOCRINE-RELATED CANCER
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Endocrine-Related Cancer, 24(10), 505-518. Bioscientifica Ltd
Endocrine-Related Cancer
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Endocrine-Related Cancer, 24(10), 505-518. Bioscientifica Ltd
Endocrine-Related Cancer
Acromegaly is a rare disorder caused by chronic growth hormone (GH) hypersecretion. While diagnostic and therapeutic methods have advanced, little information exists on trends in acromegaly characteristics over time. The Liège Acromegaly Survey (LAS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac825347dfcc6d4a250dee6069ae54ac
http://hdl.handle.net/11588/698370
http://hdl.handle.net/11588/698370
Autor:
Laurent Vroonen, Patrizio Lancellotti, Monica Tomé Garcia, Raluca Dulgheru, Matilde Almanza, Ibrahima Maiga, Julien Magne, Patrick Petrossians, Renata Auriemma, Adrian F. Daly, Albert Beckers
Publikováno v:
Endocrine
Endocrine, Springer, 2017, 55 (1), pp.239-245. ⟨10.1007/s12020-016-1120-5⟩
Endocrine, Springer, 2017, 55 (1), pp.239-245. ⟨10.1007/s12020-016-1120-5⟩
International audience; Since the 1990's cabergoline has been the treatment of choice in prolactinoma, as it permits rapid and effective hormonal and tumor control in most cases. Evidence of cardiac valvulopathy was demonstrated in Parkinson's diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91d42db96ebd8c0bbee895ccda046412
https://biblio.vub.ac.be/vubir/prospective-longterm-study-of-the-effect-of-cabergoline-on-valvular-status-in-patients-with-prolactinoma-and-idiopathic-hyperprolactinemia(011a2508-5b60-4127-95d3-028dcab57beb).html
https://biblio.vub.ac.be/vubir/prospective-longterm-study-of-the-effect-of-cabergoline-on-valvular-status-in-patients-with-prolactinoma-and-idiopathic-hyperprolactinemia(011a2508-5b60-4127-95d3-028dcab57beb).html